Inactive

Number: 12639519SSFMD1 Notice Type: Sources Sought Synopsis: Overview The U.S. Department of Agriculture, Animal and Plant Health Inspection Service, issues this sources-sought notice as a means of co... Number: 12639519SSFMD1 Notice Type: Sources Sought Synopsis: Overview The U.S. Department of Agriculture, Animal and Plant Health Inspection Service, issues this sources-sought notice as a means of conducting market research to identify interested parties with the resources to manufacture, store, and deliver Foot and Mouth Disease (FMD) vaccines. The result of this market research will contribute to determining the method of future procurement. This is not a solicitation. The applicable NAICS code assigned to this procurement is 325414 with a size standard of 1,250 employees. Background Foot and mouth disease (FMD) presents a grave threat to the U.S. livestock industry; even a small outbreak would result in devastating economic and animal health consequences. To ensure the safety of its susceptible livestock, the United States is seeking to improve its FMD vaccine preparedness by enhancing its existing stockpile of FMD vaccine. The USDA anticipates the need for FMD vaccine from multiple sources to serve the needs of the United States. The 2018 Farm Bill included funding to support the development of a National Animal Vaccine and Veterinary Countermeasures Bank (NAVVCB). The NAVVCB is distinct from the existing FMD vaccine stockpile for the United States, the North American Foot and Mouth Disease Vaccine Bank (NAFMDVB or Bank). That Bank is a trilateral partnership between the United States Department of Agriculture (USDA), the Canadian Food Inspection Agency, and the Mexican Secretariat of Agriculture, Livestock, Rural Development, Fisheries, and Food. The NAVVCB is entirely focused on U.S. domestic preparedness and is a distinct entity from the NAFMDVB. Requirement The USDA seeks to acquire sufficient quantities of vaccine or long-term vaccine precursor storage form(s) to support response activities in the case of a United States FMD outbreak. These holdings may initially be focused on inactivated products, but novel vaccine platforms or novel processes of generating inactivated vaccine will be considered, provided they meet the performance criteria detailed in this document. Commensurate with this goal, the United States is seeking information from FMD vaccine manufacturers who can meet the objectives and criteria in this document. These broadly include the following: • USDA seeks manufacturers with the capability to produce vaccine or vaccine precursor targeting current and/or previously circulating FMD topotypes. • USDA seeks manufacturers with sufficient resources to rapidly generate a vaccine or vaccine precursor for novel topotypes. • USDA seeks manufacturers with capacity for ongoing vaccine or vaccine precursor production in the face of an outbreak. • USDA is interested in a wide range of financial models to include lease access, rotating stock, buyback of vaccine/vaccine precursor, etc. Vaccine and Vaccine Precursor The vaccine, vaccine precursor or other long-term storage form(s) for consideration must meet the following requirements: • USDA seeks vaccine or vaccine precursor that targets one or more of the top ten FMD topotypes posing the highest risk to the United States as will be determined by the NAVVCB and based on data from the World Organisation for Animal Health World Reference Laboratory for FMD. • USDA seeks manufacturers capable of storing vaccine or vaccine precursor for its usable shelf life. USDA hopes to locate manufacturers of VAC with prolonged shelf life. • USDA seeks finished high-potency FMD vaccines meeting minimum threshold (? 6 PD50 or an equivalent validated measure of potency). • USDA seeks vaccines that are either licensed (fully or conditionally) or permitted by the USDA Center for Veterinary Biologics (CVB) for distribution and sale within the United States; or authorized by the Administrator to be used under the supervision and control of the Department as described in the 9 CFR 106.1 with the condition that the manufacturer is actively engaged in the pursuit of obtaining a USDA CVB product license (full or conditional) or permit. • USDA seeks products with a reasonable expectation to be safe and effective in multiple target species (i.e., cattle, swine, sheep, and goats). If your organization has the potential capacity to meet this future requirement, please provide the following information: 1) Organization name, address, email address, Web site address, telephone number, business size as determined by the NAICS code, type of ownership for the organization; and 2) Tailored capability statements addressing the particulars of this effort. THERE IS NO SOLICITATION AT THIS TIME. This request for capability information does not constitute a request for proposals; submission of any information in response to this market survey is voluntary. The government assumes no financial responsibility for any costs incurred. Based on responses to this sources-sought notice, this requirement may be set aside for small business or procured through unrestricted competition. No feedback or evaluations will be provided to companies regarding their responses to this notice. All responses must be received by 17:00 CST October 11, 2019. Please email responses with the subject line "12639519SSFMD1" to Robert Zeglin at Robert.J.Zeglin@usda.gov.